The novelty of a submitted paper is considered to be compromised if it has significant conceptual overlap with a published paper or one accepted for publication by Communications Medicine. Manuscripts that meet these editorial criteria are sent out to external referees for further assessment.
The primary editor reads the paper, consults with other members of the editorial team, and then evaluates the novelty and potential impact of the work, the appropriateness for the journal's editorial scope, the conceptual or methodological advances described in the paper, and its potential interest to the readership of Communications Medicine. Manuscripts submitted to Communications Medicine do not need to adhere to our formatting requirements at the point of initial submission formatting requirements only apply at the time of acceptance.Įach new submission is assigned to a primary editor, who may be either one of our in-house editors or an Editorial Board Member. Copies of any papers containing related work that are under consideration or in-press at other journals should be included with the submission as additional supplementary information. The corresponding author should indicate whether the work described in the manuscript has been discussed with a specific Communications Medicine editor before submission. Manuscripts should be submitted via the online submission system. All manuscripts received with reviewer comments from another Nature Portfolio journal via the manuscript transfer service will be handled only by our in-house editors. However, the assignment of manuscripts to editors is at the discretion of the chief editor. Authors may request that a specific editor be considered for handling the review process of their paper. Research papers published by the journal represent significant advances in preventing, diagnosing, or treating human disease of relevance to a specialized field.Įditorial decisions at Communications Medicine may be made either by in-house editors or Editorial Board Members. Communications Medicine is a selective open access journal from Nature Portfolio publishing high-quality research, reviews and commentary across all clinical, translational, and public health reserch fields.
0 kommentar(er)
